Regen BioPharma, Inc., announced the filing with the United States Patent and Trademark Office of a provisional patent application covering utilization of dendritic cell...
Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new live...
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the first patient has been dosed in a...
Ginkgo Bioworks — the leading horizontal platform for cell programming — and the biotechnology company Zymergen announced they have entered into a definitive agreement...
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
